A laboratory-scale capsule filling machine that, for the first
time, allows reproducible scale-up of powder dosing to full size
production models, has been launched in the UK by Sussex &
Berkshire Machinery.
Fast-melt tablets are a growing category in oral drug delivery,
driven by their ease of use. To date, products of this type have
needed specialised packaging to ensure they arrive at the consumer
in good condition, but a new technology...
Switzerland's Dr Schleuniger Pharmatron has launched a new handling
system for its 8M testing machine that reduces the amount of
operator time to conduct quality control of the weight, thickness,
diameter and hardness of tablets.
UK tablet press and coating machine specialist Manesty will
introduce another product in its Xpress range at the TOTAL 2004
show next month as it navigates the sea-change in its business that
has emerged over the last few years.
Tablet-coating specialist BioProgress formalised its agreement with
US chemicals and machinery group FMC in deal that could be worth up
to $160 million (€128m) in revenues in the first six years.
Irish pharmaceutical group Elan has raised around $70 million
(€55m) from four new deals, including the sale of formulation and
manufacturing interests.
A survey has found that difficulties in swallowing pills is
widespread among adults, but is rarely discussed with doctors and
can prevent some people from taking their medicine. The findings
suggest that pharmaceutical companies should...
In 2003, Freeman Technology launched its new-generation FT4
rheometer in Europe for testing the flow properties of powders, an
important measurement in the pharmaceutical and chemical industries
where most processes involve the extensive...
Isopak of the UK will be unveiling the latest version of the
automatic benchtop In-Cap capsule-filling machine at the Total
Solutions show in Birmingham, UK, in the spring.
UK encapsulation company BioProgress yesterday unveiled plans to
raise £6.6 million (€9.4m) through a placement of shares in order
to build a new pharmaceutical production plant.
The new agreement between BioProgress and an unnamed US
over-the-counter pharmaceuticals firm could double the UK company's
capacity to manufacture cellulose films for drug encapsulation,
according to chief executive Graham Hind.
Micap, which specialises in using yeast and other organisms as
microcapsules for protecting active compounds, is set to expand its
business after extricating itself from an 'onerous' license with
Unilever Bestfoods.
International Journal of Pharmceutics: In Vitro: The dissolution characteristics of five capsules (Next Generation Enteric [NGE], Vcaps® Enteric [VCE],...
